tirzepatide meta analysis Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis | Diabetologia Adding tirzepatide to basal insulin
Description
It's about having the right tools, the right medical oversight, and a plan built for your body
1 2 But what happens if you need to stop taking these medications
Fintini D, Grugni G, Brufani C, Bocchini S, Cappa M, Crin A
As a dual GIP and GLP-1 receptor agonist, it works by slowing gastric emptying, enhancing insulin secretion, and promoting satiety
BUT REMEMBER, PEOPLE WHO STOP THESE MEDICATIONS ABOUT YOU GAIN ABOUT TWO THIRDS OF THE WEIGHT
Do not use your medication if you are pregnant or breastfeeding, or planning to become pregnant or breastfeed
